Freya Trautmann1,2, Leopold Hentschel3, Beate Hornemann4, Anke Rentsch4, Michael Baumann4, Gerhard Ehninger4, Jochen Schmitt1, Markus Schuler4,5. 1. Center for Evidence Based Healthcare (ZEGV), Medical Faculty Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany. 2. National Center for Tumor Diseases (NCT), Partner Site Dresden and German Cancer Research Center (DKFZ), Dresden, Germany. 3. University Cancer Center, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany. Leopold.Hentschel@uniklinikum-dresden.de. 4. University Cancer Center, University Hospital Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany. 5. Clinic for Internal Medicine II, HELIOS Hospital Emil von Behring, Walterhöferstraße 11, 14165, Berlin, Germany.
Abstract
PURPOSE: Cancer patients suffer from a variety of physical and mental complaints. Since physician assessment of symptoms seems insufficient to reveal the complete range of patients' ailments, patient-reported outcomes (PRO) have become of key importance in modern cancer treatment. The implementation and first results of a systematic electronic real-time assessment of PRO in routine care is described. METHODS: Consecutive patients presenting for the first time to a German comprehensive cancer center were asked to fill in an adaptive self-administered electronic questionnaire consisting of standardized PRO measures. After completion, patient-reported data was linked to the patients' medical files for discussion in the first consultation with the treating physician. Interviews with staff were conducted to identify barriers in implementation. RESULTS: Out of 160 cancer patients, 126 (79 %; mean age 63 years, 67 % males) agreed to participate. The number of recruited patients increased over time. Of participating patients, 67 % provided complete information on all PRO-related scales. On average, 31 min (range 3-140) were required to fill in the questionnaire. Of participating patients, 53.0 % comprised need for psychooncological support and 62 % revealed moderate to severe psychosocial distress. The mean score for global quality of life according to the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) was 55.2 (SD ±25.6). CONCLUSIONS: Comprehensive oncological treatment needs to consider disease symptoms, quality of life, preferences, and comorbidities of individual patients in a structured, standardized, and transparent way. Our findings indicate that an adaptive, self-administered electronic assessment tool for cancer patients to report a broad set of PRO can be feasibly implemented and is well accepted by patients in a realistic setting.
PURPOSE:Cancerpatients suffer from a variety of physical and mental complaints. Since physician assessment of symptoms seems insufficient to reveal the complete range of patients' ailments, patient-reported outcomes (PRO) have become of key importance in modern cancer treatment. The implementation and first results of a systematic electronic real-time assessment of PRO in routine care is described. METHODS: Consecutive patients presenting for the first time to a German comprehensive cancer center were asked to fill in an adaptive self-administered electronic questionnaire consisting of standardized PRO measures. After completion, patient-reported data was linked to the patients' medical files for discussion in the first consultation with the treating physician. Interviews with staff were conducted to identify barriers in implementation. RESULTS: Out of 160 cancerpatients, 126 (79 %; mean age 63 years, 67 % males) agreed to participate. The number of recruited patients increased over time. Of participating patients, 67 % provided complete information on all PRO-related scales. On average, 31 min (range 3-140) were required to fill in the questionnaire. Of participating patients, 53.0 % comprised need for psychooncological support and 62 % revealed moderate to severe psychosocial distress. The mean score for global quality of life according to the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) was 55.2 (SD ±25.6). CONCLUSIONS: Comprehensive oncological treatment needs to consider disease symptoms, quality of life, preferences, and comorbidities of individual patients in a structured, standardized, and transparent way. Our findings indicate that an adaptive, self-administered electronic assessment tool for cancerpatients to report a broad set of PRO can be feasibly implemented and is well accepted by patients in a realistic setting.
Entities:
Keywords:
Electronic assessment; Oncology; Patient care; Patient-reported outcomes; Quality of life; Routine care
Authors: K Cocks; M T King; G Velikova; G de Castro; M Martyn St-James; P M Fayers; J M Brown Journal: Eur J Cancer Date: 2012-03-12 Impact factor: 9.162
Authors: Morten Aa Petersen; Mogens Groenvold; Neil K Aaronson; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Peter Fayers; Jorunn Helbostad; Bernhard Holzner; Stein Kaasa; Susanne Singer; Galina Velikova; Teresa Young Journal: Eur J Cancer Date: 2010-03-16 Impact factor: 9.162
Authors: Chantal Quinten; John Maringwa; Carolyn C Gotay; Francesca Martinelli; Corneel Coens; Bryce B Reeve; Henning Flechtner; Eva Greimel; Madeleine King; David Osoba; Charles Cleeland; Jolie Ringash; Joseph Schmucker-Von Koch; Martin J B Taphoorn; Joachim Weis; Andrew Bottomley Journal: J Natl Cancer Inst Date: 2011-12-07 Impact factor: 13.506
Authors: M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn Journal: Ann Oncol Date: 2007-03-12 Impact factor: 32.976
Authors: L E Carlson; M Angen; J Cullum; E Goodey; J Koopmans; L Lamont; J H MacRae; M Martin; G Pelletier; J Robinson; J S A Simpson; M Speca; L Tillotson; B D Bultz Journal: Br J Cancer Date: 2004-06-14 Impact factor: 7.640
Authors: Markus Schuler; Jan Schildmann; Freya Trautmann; Leopold Hentschel; Beate Hornemann; Anke Rentsch; Gerhard Ehninger; Jochen Schmitt Journal: Support Care Cancer Date: 2017-03-29 Impact factor: 3.603
Authors: Emily R Haines; M Alexis Kirk; Lauren Lux; Andrew B Smitherman; Byron J Powell; Alex Dopp; Angela M Stover; Sarah A Birken Journal: Transl Behav Med Date: 2022-01-18 Impact factor: 3.626
Authors: Joachim Graf; Sara Y Brucker; Markus Wallwiener; Lina Matthies; Elisabeth Simoes; Lucia Keilmann; Andreas D Hartkopf; Alexander N Sokolov; Christina B Walter; Nina Sickenberger; Stephanie Wallwiener; Manuel Feisst; Paul Gass; Peter A Fasching; Michael P Lux; Diethelm Wallwiener; Florin-Andrei Taran; Joachim Rom; Andreas Schneeweiss Journal: J Med Internet Res Date: 2017-09-14 Impact factor: 5.428
Authors: Lina Maria Matthies; Florin-Andrei Taran; Joachim Graf; Markus Wallwiener; Lucia Keilmann; Andreas Schneeweiss; Elisabeth Simoes; Andreas D Hartkopf; Alexander N Sokolov; Christina B Walter; Nina Sickenberger; Stephanie Wallwiener; Manuel Feisst; Paul Gass; Michael P Lux; Florian Schuetz; Peter A Fasching; Christof Sohn; Sara Y Brucker Journal: J Med Internet Res Date: 2019-01-22 Impact factor: 5.428
Authors: Christiane Rudolph; Gitte Stentebjerg Petersen; Ron Pritzkuleit; Hans Storm; Alexander Katalinic Journal: BMC Health Serv Res Date: 2019-11-01 Impact factor: 2.655